Understanding radiation-induced cardiovascular damage and strategies for intervention

Clinical Oncology

Volumn 25, Issue 10, 2013, Pages 617-624

  Stewart, F A ^a   Seemann, I ^a   Hoving, S ^a   Russell, N S ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Atherosclerosis; Cardiovascular disease; Microvascular damage; Radiation

Indexed keywords

CAPTOPRIL; ENALAPRIL;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHILDHOOD CANCER; CORONARY ARTERY ATHEROSCLEROSIS; HEART DEATH; HEART INFARCTION; HEART INJURY; HEART MUSCLE FIBROSIS; HODGKIN DISEASE; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; MICROVASCULAR DAMAGE; RADIATION;

CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; RADIATION INJURIES; THORAX;

EID: 84883276632     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.06.012     Document Type: Article

References (102)

1. Adams M.J., Hardenbergh P.H., Constine L.S., Lipshultz S.E. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003, 45:55-75.
2. Andratschke N., Maurer J., Molls M., Trott K.R. Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol 2011, 100:160-166.
3. Darby S.C., Cutter D.J., Boerma M., et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010, 76:656-665.
4. Filopei J., Frishman W. Radiation-induced heart disease. Cardiol Rev 2012, 20:184-188.
5. Schultz-Hector S., Trott K.R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int J Radiat Oncol Biol Phys 2007, 67:10-18.
6. Stewart F.A., Hoving S., Russell N.S. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 2010, 174:865-869.
7. Adams M.J., Lipsitz S.R., Colan S.D., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. JClin Oncol 2004, 22:3139-3148.
8. Aleman B.M., van den Belt-Dusebout A.W., De Bruin M.L., et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007, 109:1878-1886.
9. Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. JClin Oncol 1993, 11:1208-1215.
10. Swerdlow A.J., Higgins C.D., Smith P., et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. JNatl Cancer Inst 2007, 99:206-214.
11. Heidenreich P.A., Hancock S.L., Vagelos R.H., Lee B.K., Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005, 150:977-982.
12. Mulrooney D.A., Yeazel M.W., Kawashima T., et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. Br Med J 2009, 339:b4606.
13. Tukenova M., Guibout C., Oberlin O., et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. JClin Oncol 2010, 28:1308-1315.
14. Darby S.C., McGale P., Taylor C.W., Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-565.
15. Gaya A.M., Ashford R.F. Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol) 2005, 17:153-159.
16. Senkus-Konefka E., Jassem J. Cardiovascular effects of breast cancer radiotherapy. Cancer Treat Rev 2007, 33:578-593.
17. Taylor C.W., Nisbet A., McGale P., Darby S.C. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 2007, 69:1484-1495.
18. Hooning M.J., Botma A., Aleman B.M., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. JNatl Cancer Inst 2007, 99:365-375.
19. Borst G.R., Sonke J.J., den Hollander S., et al. Clinical results of image-guided deep inspiration breath hold breast irradiation. Int J Radiat Oncol Biol Phys 2010, 78:1345-1351.
20. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
21. McGale P., Darby S.C., Hall P., et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011, 100:167-175.
22. Darby S.C., Ewertz M., McGale P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. New Engl J Med 2013, 368:987-998.
23. Gyenes G., Fornander T., Carlens P., Glas U., Rutqvist L.E. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 1996, 36:899-905.
24. Marks L.B., Yu X., Prosnitz R.G., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 2005, 63:214-223.
25. Seddon B., Cook A., Gothard L., et al. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 2002, 64:53-63.
26. Chera B.S., Rodriguez C., Morris C.G., et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75:1173-1180.
27. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003, 160:381-407.
28. Shimizu Y., Kodama K., Nishi N., et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. Br Med J 2010, 340:b5349.
29. Shimizu Y., Pierce D.A., Preston D.L., Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res 1999, 152:374-389.
30. Hayashi T., Kusunoki Y., Hakoda M., et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int J Radiat Biol 2003, 79:129-136.
31. Sasaki H., Wong F.L., Yamada M., Kodama K. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. JClin Epidemiol 2002, 55:974-981.
32. Wong F.L., Yamada M., Sasaki H., Kodama K., Hosoda Y. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res 1999, 151:736-746.
33. Adams M.J., Grant E.J., Kodama K., et al. Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation. Radiat Res 2012, 177:220-228.
34. Effects of ionizing radiation, Report to the General Assembly, Scientific Annexes A and B. Radiation UNSCotEoA 2006, UNSCEAR 2008, United Nations, New York.
35. Little M.P., Azizova T.V., Bazyka D., et al. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect 2012, 120:1503-1511.
36. Little M.P., Tawn E.J., Tzoulaki I., et al. Asystematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat Res 2008, 169:99-109.
37. Little M.P., Tawn E.J., Tzoulaki I., et al. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys 2010, 49:139-153.
38. McGale P., Darby S.C. Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiat Res 2005, 163:247-257.
39. McGale P., Darby S.C. Commentary: a dose-response relationship for radiation-induced heart disease - current issues and future prospects. Int J Epidemiol 2008, 37:518-523.
40. Metz-Flamant C., Bonaventure A., Milliat F., Tirmarche M., Laurier D., Bernier M.O. [Low doses of ionizing radiation and risk of cardiovascular disease: a review of epidemiological studies]. Rev Epidemiol Sante Publique 2009, 57:347-359.
41. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
42. Khaled S., Gupta K.B., Kucik D.F. Ionizing radiation increases adhesiveness of human aortic endothelial cells via a chemokine-dependent mechanism. Radiat Res 2012, 177:594-601.
43. Hewitt G., Jurk D., Marques F.D., et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012, 3:708.
44. Konings A.W., Smit Sibinga C.T., Aarnoudse M.W., de Wit S.S., Lamberts H.B. Initial events in radiation-induced atheromatosis. II. Damage to intimal cells. Strahlentherapie 1978, 154:795-800.
45. Stewart J.R., Fajardo L.F., Gillette S.M., Constine L.S. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995, 31:1205-1211.
46. Veinot J.P., Edwards W.D. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996, 27:766-773.
47. Tribble D.L., Barcellos-Hoff M.H., Chu B.M., Gong E.L. Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes. Arterioscler Thromb Vasc Biol 1999, 19:1387-1392.
48. Gabriels K., Hoving S., Seemann I., et al. Local heart irradiation of ApoE(-/-) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother Oncol 2012, 105:358-364.
49. Hoving S., Heeneman S., Gijbels M.J., et al. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(-/-) mice. Int J Radiat Oncol Biol Phys 2008, 71:848-857.
50. Pakala R., Leborgne L., Cheneau E., et al. Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: a prospective vulnerable plaque model?. Cardiovasc Radiat Med 2003, 4:146-151.
51. Stewart F.A., Heeneman S., Te Poele J., et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 2006, 168:649-658.
52. Vos J., Aarnoudse M.W., Dijk F., Lamberts H.B. On the cellular origin and development of atheromatous plaques. A light and electron microscopic study of combined X-ray and hypercholesterolemia-induced atheromatosis in the carotid artery of the rabbit. Virchows Arch B Cell Pathol Incl Mol Pathol 1983, 43:1-16.
53. Yu T., Parks B.W., Yu S., et al. Iron-ion radiation accelerates atherosclerosis in apolipoprotein E-deficient mice. Radiat Res 2011, 175:766-773.
54. Baker J.E., Fish B.L., Su J., et al. 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 2009, 85:1089-1100.
55. Mitchel R.E., Hasu M., Bugden M., et al. Low-dose radiation exposure and atherosclerosis in ApoE(-)/(-) mice. Radiat Res 2011, 175:665-676.
56. Hildebrandt G., Maggiorella L., Rodel F., Rodel V., Willis D., Trott K.R. Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells invitro. Int J Radiat Biol 2002, 78:315-325.
57. Arenas M., Gil F., Gironella M., et al. Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice. Int J Radiat Oncol Biol Phys 2006, 66:560-567.
58. Fajardo L.F., Stewart J.R. Experimental radiation-induced heart disease. I. Light microscopic studies. Am J Pathol 1970, 59:299-316.
59. Fajardo L.F., Berthrong M., Anderson R.E. Radiation pathology 2001, Oxford University Press, New York.
60. Lauk S. Endothelial alkaline phosphatase activity loss as an early stage in the development of radiation-induced heart disease in rats. Radiat Res 1987, 110:118-128.
61. Schultz-Hector S. Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int J Radiat Biol 1992, 61:149-160.
62. Seemann I., Gabriels K., Visser N.L., et al. Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol 2012, 103:143-150.
63. Lauk S., Trott K.R. Endothelial cell proliferation in the rat heart following local heart irradiation. Int J Radiat Biol 1990, 57:1017-1030.
64. Kanthou C., Gharaei Z., Haagen J., et al. Inhibition of angiogenesis in the mouse heart by ionizing radiation 2012, AACR 103rd Annual Meeting, Cancer Research, Chicago.
65. Lauk S., Kiszel Z., Buschmann J., Trott K.R. Radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys 1985, 11:801-808.
66. McChesney S.L., Gillette E.L., Orton E.C. Canine cardiomyopathy after whole heart and partial lung irradiation. Int J Radiat Oncol Biol Phys 1988, 14:1169-1174.
67. Boerma M., Wang J., Wondergem J., et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res 2005, 65:3100-3107.
68. Lara P.C., Russell N.S., Smolders I.J., Bartelink H., Begg A.C., Coco-Martin J.M. Radiation-induced differentiation of human skin fibroblasts: relationship with cell survival and collagen production. Int J Radiat Biol 1996, 70:683-692.
69. Rodemann H.P., Peterson H.P., Schwenke K., von Wangenheim K.H. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 1991, 12:1135-1142. discussion 1142-1143.
70. Russell N.S., Lara P.C., Grummels A., et al. Invitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients. Int J Radiat Biol 2000, 76:231-240.
71. Kruse J.J., Zurcher C., Strootman E.G., et al. Structural changes in the auricles of the rat heart after local ionizing irradiation. Radiother Oncol 2001, 58:303-311.
72. Burger A., Loffler H., Bamberg M., Rodemann H.P. Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 1998, 73:401-408.
73. Evans R.A., Tian Y.C., Steadman R., Phillips A.O. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation - the role of Smad proteins. Exp Cell Res 2003, 282:90-100.
74. Hilbers F.S., Boekel N.B., van den Broek A.J., et al. Genetic variants in TGFbeta-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. Radiother Oncol 2012, 102:115-121.
75. Monceau V., Pasinetti N., Schupp C., Pouzoulet F., Opolon P., Vozenin M.C. Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity. Curr Drug Targets 2010, 11:1395-1404.
76. Heidenreich P.A., Schnittger I., Strauss H.W., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. JClin Oncol 2007, 25:43-49.
77. Nadlonek N.A., Weyant M.J., Yu J.A., et al. Radiation induces osteogenesis in human aortic valve interstitial cells. JThorac Cardiovasc Surg 2012, 144:1466-1470.
78. Ghobadi G., Bartelds B., van der Veen S.J., et al. Lung irradiation induces pulmonary vascular remodelling resembling pulmonary arterial hypertension. Thorax 2012, 67:334-341.
79. Schiller N.K., Kubo N., Boisvert W.A., Curtiss L.K. Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21:1674-1680.
80. Hoving S., Heeneman S., Gijbels M.J., et al. NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice. PLoS One 2010, 5:e12874.
81. Momi S., Pitchford S.C., Alberti P.F., Minuz P., Del Soldato P., Gresele P. Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice. Thromb Haemost 2005, 93:535-543.
82. Napoli C. Nitric oxide and atherosclerotic lesion progression: an overview. JCard Surg 2002, 17:355-362.
83. Yu H., Kumar S.R., Tang L., et al. Injury induced neointima formation and its inhibition by retrovirus-mediated transfer of nitride oxide synthase gene in an in-vitro human saphenous vein culture model. Atherosclerosis 2002, 161:113-122.
84. Li M., Zhang Y., Ren H., Zhu X. Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 2007, 194:348-356.
85. Waksman R., Pakala R., Roy P., et al. Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries. JInterv Cardiol 2008, 21:122-128.
86. Hoving S., Heeneman S., Gijbels M.J., et al. Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice. Radiother Oncol 2011, 101:100-108.
87. Leborgne L., Pakala R., Dilcher C., et al. Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits. JCardiovasc Pharmacol 2005, 46:540-547.
88. Pakala R., Dilcher C., Baffour R., et al. Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit. JCardiovasc Pharmacol 2006, 48:299-305.
89. van der Hoorn J.W., Jukema J.W., Havekes L.M., et al. The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice. Br J Pharmacol 2009, 156:1067-1075.
90. Shi J., Wang J., Zheng H., et al. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis 2003, 14:575-585.
91. Trochu J.N., Mital S., Zhang X., et al. Preservation of NO production by statins in the treatment of heart failure. Cardiovasc Res 2003, 60:250-258.
92. Haydont V., Mathe D., Bourgier C., et al. Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. Radiother Oncol 2005, 76:219-225.
93. Dai W., Kloner R.A. Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions. Am J Transplant 2011, 11:2297-2301.
94. Kumar A.H., Caplice N.M. Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 2010, 30:1080-1087.
95. Yuen D.A., Connelly K.A., Advani A., et al. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One 2010, 5:e9543.
96. Jujo K., Li M., Losordo D.W. Endothelial progenitor cells in neovascularization of infarcted myocardium. JMol Cell Cardiol 2008, 45:530-544.
97. Boerma M., Roberto K.A., Hauer-Jensen M. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 2008, 72:170-177.
98. Liu H., Xiong M., Xia Y.F., et al. Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys 2009, 73:1552-1559.
99. Delanian S., Porcher R., Rudant J., Lefaix J.L. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. JClin Oncol 2005, 23:8570-8579.
100. Magnusson M., Hoglund P., Johansson K., et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer 2009, 45:2488-2495.
101. Yarom R., Harper I.S., Wynchank S., et al. Effect of captopril on changes in rats' hearts induced by long-term irradiation. Radiat Res 1993, 133:187-197.
102. Cardinale D., Colombo A., Sandri M.T., et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 2006, 114:2474-2481.